FIELD: medicine.
SUBSTANCE: invention refers to preventive medicine, and may be used for preventing and treating atherosclerosis. That is ensured by prescribing a natural complex an active component of which is licorice root, while the additives are lactose, polyvinyl pyrrolidone and calcium stearate in the following proportions: - in a tablet (wt %) 51.42-62.86; 32.22-39.38; 4.5-5.5; 1.84-2.26; - in a capsule (wt %) 60.00-73.33; 25.50-31.17; 2.70-3.30; 1.80-2.20, with the complex taken in a dose of one capsule 300 mg or one tablet 350 mg twice a day with food for three weeks.
EFFECT: method enables inhibiting the formation of new atherosclerotic involvements almost completely and slowing the progression of existing ones in 1,5 times through inhibition of blood sialidase activity.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING ATHEROSCLEROSIS HAVING ANTI-CYTOKINE ACTION | 2012 |
|
RU2539377C2 |
| METHOD FOR PREVENTING AND TREATING ATHEROSCLEROSIS | 2011 |
|
RU2455016C1 |
| AGENT NORMALIZING METABOLISM | 2001 |
|
RU2197980C1 |
| MEDICATION FOR PREVENTION AND TREATMENT OF ATHEROSLEROSIS | 2011 |
|
RU2468789C1 |
| ANTI-ISCHEMIC AND ANTI-ATHEROSCLEROTIC DRUG | 1998 |
|
RU2144822C1 |
| PHARMACEUTICAL POSSESSING HYPOLIDEMIC, HEPATOPROTECTIVE AND ANTIOXIDANT ACTION | 2016 |
|
RU2636817C2 |
| AGENT FOR TREATING HOT FLASHES AND RECUPERATING MENSTRUAL CYCLE DURING PERIMENOPAUSE AND METHOD OF USING IT | 2019 |
|
RU2736997C1 |
| AGENT WITH IMMUNOMODULATING PROPERTIES FOR PREVENTION OF ATHEROSCLEROSIS | 2014 |
|
RU2597161C2 |
| PHARMACEUTICAL COMPOSITION OF ANTIDIABETIC ACTION IN SOLID DOSAGE FORM IN THE FORM OF TABLETS | 2022 |
|
RU2801279C1 |
| OFFICINAL TEA FOR TREATMENT OF PATIENTS SUFFERING FROM THROMBUS OCCLUSION INJURY OF HEAD AND NECK ARTERIES | 2006 |
|
RU2313359C1 |
